Stock Ticker

  • Loading stock data...

Eli Lilly And Co (NYSE:LLY) Commences First Human Trial Involving Its Antibody-based COVID-19 Treatment

Eli Lilly And Co (NYSE:LLY) revealed on Monday that it started testing human subjects with its developmental treatment for COVID-19, which is based on antibodies. The biopharma is currently working on phase 1 of the clinical trial, through which it aims to test the safety and efficacy of the drug. Eli Lilly plans to publish […]

Gilead Sciences, Inc. (NASDAQ:GILD) Reports Minor Benefits Of Remdesivir In COVID-19 Patients

Gilead Sciences, Inc. (NASDAQ:GILD) released an update about its developmental COVID-19 vaccine remdesivir, revealing that the treatment yielded modest improvements in patients. Coronavirus patients who were administered with remdesivir intravenously for five days demonstrated moderate improvements. However, the COVID-19 patients that were treated with the drug for 10-days did not yield significant improvements. Remdesivir was […]

Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul

Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock price, but the announcement also yielded some criticism. The U.S-based biotech revealed that the initial results of its coronavirus vaccine were promising. This was enough to encourage positive sentiments regarding […]

Novavax, Inc (NASDAQ:NVAX) Chooses Australia For Its COVID-19 Clinical Trials

The deadly COVID-19 pandemic continues to affect lives globally, with many people hardly affording to pay their house rent. It is frustrating that until no scientific cure to help handle the condition has been established yet. However, any good efforts mean a lot to frustrated people globally. There are reports about another candidate that is […]

Is the PPE Theme Ready to Catch Fire? (APT, LAKE, BLGO, MMM)

The COVID-19 pandemic has forced a reimagining of life in the developed world to a far greater extent than most anything since World War II. As we endure this collective battle, there are few subjects that spark populist anger more than personal protection equipment (PPE) and its lack of availability for frontline workers – not […]

Moderna Inc. (NASDAQ:MRNA) Releases Positive Data For Its Coronavirus Vaccine Candidate In Human Trials

Moderna Inc. (NASDAQ:MRNA) has released positive data from its first human trials for its COVID-19 vaccine candidate, demonstrating that the healthy volunteers who received the vaccine developed antibody responses. Moderna’s vaccine in humans shows positive immunity response The company which had partnered with the National Institute of Health in developing the vaccine indicated that there […]

Abbott Laboratories’ (NYSE:ABT) ID NOW test May Be Giving Inaccurate Test Results Due To “User Error”

The US FDA has warned that Abbott Laboratories’ (NYSE:ABT) rapid COVID-19 test might be having accuracy issues that might be due to user error. The FDA cited various studies that have raised concerns about the test’s accuracy when employed in making a quick diagnosis. Abbott’s rapid test could be giving inaccurate results Alex Azar, the […]

The Coronavirus Coping Portfolio (QDEL, GILD, QBIO, CYDY)

The COVID-19 pandemic has forced a dramatic realignment of social, cultural, and economic agendas because, in all cases, the healthcare issue has priority. It’s not a genuine public debate – if you don’t solve the healthcare crisis, you can’t solve any of the other crises that have been boiling over in the public discourse. That […]

Gilead Sciences, Inc (NASDAQ:GILD) Speaks Out On The Trial Of Its Remdesivir Drug

Gilead Sciences, Inc (NASDAQ:GILD) is pleased to report about the success it is witnessing with its vaccine Remdesivir. The scientists have been working on the product in the hope that it would turn out to be the vaccine that would possibly help in dealing with COVID-19. Gilead has given an update outlining that it is […]

Gilead Sciences’ (NASDAQ:GILD) Potential COVID-19 Treatment Can Not Undo Damage On The US Economy

Gilead Sciences (NASDAQ:GILD) has a promising COVID-19 cure called remdesivir which caused US equity markets to surge on Friday. However, the surge in the stock market on Friday isn’t something justifiable. Is the economy gearing for fake markets? For stock markets, it has been a gloomy past few weeks and the economy could receive a […]

Johnson & Johnson (NYSE:JNJ) Expects To Deliver Over 1 Billion Doses Of Vaccine For COVID-19 And Commence Clinical Trials By September 2020

Johnson & Johnson (NYSE:JNJ) has decided to produce over 1 billion doses of vaccine for COVID-19 by teaming up with the Biomedical Advanced Research and Development Authority (BARDA) in the US. It is an extension of the existing accord between the Janssen Pharmaceutical Companies division of Johnson & Johnson and BARDA. The first batch of affordable […]

Target Corporation (NYSE:TGT) and Kroger Co (NYSE:KR) Ramp Up Fight Against COVID-19 in Stores

Retail giants Target Corporation (NYSE:TGT) and  Kroger Co (NYSE:KR) are doing everything in their power to maintain operations, even as the Corona pandemic continues to trigger massive shutdown across the U.S. The two retailers have resorted to ingenious ways to try and curb the spread of the coronavirus within their brick and mortar stores. COVID-19 […]

Investing in the Age of Coronavirus (INO, APT, CODX, SGMD, IBIO, AYTU)

The market is crashing almost every day right now. If you own the SPY, or a basket of large-cap leadership stocks that have defined this bull market for years, you’re getting destroyed over the past three weeks. But there is an answer. A small group of stocks has been rallying precisely because of the impact […]

Gilead Sciences Inc. (NASDAQ:GILD) Commences Two Phase 3 Clinical Trials of Remdesivir For COVID-19 Treatment

Gilead Sciences Inc. (NASDAQ:GILD) has announced that it is expanding clinical trials for its antiviral drug remdesivir as a potential treatment of COVID-19 in countries outside China. Gilead to expand clinical trials of remdsivir to other countries outside china The company now expects to begin two new remdesivir clinical trials in March across Asia and […]

Walgreens Boots Alliance (NASDAQ: WBA) To Pay $7.5 Million To Settle Lawsuit Regarding Unlicensed Pharmacist

Walgreens Boots Alliance (NASDAQ:WBA) has agreed to settle a consumer protection lawsuit by paying $7.5 million after Alameda County District Attorney claimed that one of Walgreens ’pharmacists had worked in the Bay Area over a decade without a license. Walgreens pharmacist handled 745,000 prescriptions without a license. Prosecutors indicated that Kim Thien Le had handled […]

Sign Up To Get Our Latest Stocks Alerts